Andreia Albuquerque graduated from the Faculty of Medicine of the University of Coimbra, Portugal in 2007. From 2009 to 2013 she completed her Gastroenterology residency at Hospital São João, Porto, Portugal, which is a European Board of Gastroenterology & Hepatology certified centre. From April 2014 to March 2017, she worked as a Consultant Gastroenterologist in this Department and as a teaching assistant of the Faculty of Medicine of the University of Porto, Portugal. In her Department, she was directly responsible for the Proctology outpatient clinic/Anal Neoplasia outpatient clinic since 2014. During her career she received several awards and scholarships. She won the Oncology Prize in 2007, from the Faculty of Medicine of the University of Coimbra and the 2013 Portuguese Hepatology Scholarship. In 2013, she won the Journal of Gastroenterology and Hepatology Foundation (JGHF) travel grant to attend the World Congress of Gastroenterology in Shanghai, China and, in 2017 the UEG travel grant award to attend the UEG week in Barcelona. She has more than 100 oral and poster presentations in national and international scientific meetings and has participated in several national and multicentre international trials. She currently has a total of 53 published papers in peer-reviews journals. She acts as a reviewer for several Journals, namely: World Journal of Gastrointestinal Endoscopy, World Journal of Gastroenterology, Scandinavian Journal of Gastroenterology, Digestive Disease and Sciences, European Medical Journal of Gastroenterology, Portuguese Journal of Gastroenterology. She is an acting board member of the Portuguese Coloproctology Society and a member of the International Continence Society Committee on male anorectal dysfunction terminology. In 2014, she started her PhD on “Anal squamous intraepithelial lesions” at the Faculty of Medicine of the University of Porto, Portugal (PhD in Medicine and Molecular Oncology). Her major research interests are on biomarkers and epidemiology of less well-studied high-risk populations, such as pharmacologically immunosuppressed patients and high-risk women. From April 2017 to April 2018), she has been conducting clinical research at the Homerton University Hospital/Homerton Anal Neoplasia Service.